Kamlesh M. Thakker

Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin‐Treated Subjects From 3 Data Sources: A Retrospective Analysis

Peter H. Jones, Radhika Nair, Kamlesh M. Thakker · Journal of the American Heart Association · 2012 · 118 citations · Full text

The electrocardiographic effects of cetirizine in normal subjects

Mark Sale, Jean T. Barbey, Raymond L. Woosley et al. · Clinical Pharmacology & Therapeutics · 1994 · 67 citations

Bacterial endotoxin retention by inline intravenous filters

Thomas G. Baumgartner, Gerald Schmidt, Kamlesh M. Thakker et al. · American Journal of Health-System Pharmacy · 1986 · 40 citations

E. Coli Endotoxin, Microbial Contamination, Antimicrobial Susceptibility +11

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus

Peter H. Jones, Kenneth Cusi, Michael H. Davidson et al. · American Journal of Cardiovascular Drugs · 2010 · 39 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dosage form and formulation effects on the bioavailability of vitamin E, riboflavin, and vitamin B-6 from multivitamin preparations

Kamlesh M. Thakker, Harry S. Sitren, Jesse F. Gregory et al. · American Journal of Clinical Nutrition · 1987 · 24 citations

Vitamin E, Nutrition, Nutrient Bioavailability +8